zosuquidar trihydrochloride
(ZOH-soo-KWIH-dar try-HY-droh-KLOR-ide)
A substance being studied in the treatment of cancer. Zosuquidar trihydrochloride may help kill cancer cells that are resistant to anticancer drugs. Also called LY335979.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at opm.gov.